Jason Marc Maille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Kotzebue, AK 99752 Phone: 907-442-7182 |
Dr. Joshua Fillible, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Ave, Kotzebue, AK 99752 Phone: 907-442-7462 |
Mr. Freddy Rukema Kaniki, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 439 5th & Grizzly, Kotzebue, AK 99752 Phone: 907-442-7182 |
Maher Shenouda, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Ave, Kotzebue, AK 99752 Phone: 907-442-7457 Fax: 907-442-7245 |
Denzel Mann, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Maniilaq Health Center, Kotzebue, AK 99752 Phone: 757-254-4481 |
Paul F Nunamaker, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 439 5th & Grizzly, Maniilaq Association, Kotzebue, AK 99752 Phone: 907-442-7182 |
Meredith A Dean, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-7182 Fax: 907-442-7309 |
News Archive
Day of the week did not affect the survival chances of people undergoing emergency surgery, research has found.
Twenty minutes per day of guided workplace meditation and yoga combined with six weekly group sessions can lower feelings of stress by more than 10 percent and improve sleep quality in sedentary office employees, a pilot study suggests.
Instead of granting automatic pay increases, N.Y. City's public hospital system will pay them based on how well they reduce costs, increase patient satisfaction and improve the quality of care. The Health and Hospitals Corporation, which runs the city's 11 public hospitals, deserves praise for an ambitious proposal that will need to be refined as it is put into practice.
Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry.
Abbott (NYSE: ABT) announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.
› Verified 9 days ago